Research output per year
Research output per year
Fingerprint
Dive into the research topics where Neil Johnson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress
Calbert, M. L., Chandramouly, G., Adams, C. M., Saez-Ayala, M., Kent, T., Tyagi, M., Ayyadevara, V. S. S. A., Wang, Y., Krais, J. J., Gordon, J., Atkins, J., Toma, M. M., Betzi, S., Boghossian, A. S., Rees, M. G., Ronan, M. M., Roth, J. A., Goldman, A. R., Gorman, N. & Mitra, R. & 8 others, , May 1 2024, In: Molecular Cancer Therapeutics. 23, 5, p. 683-699 17 p.Research output: Contribution to journal › Article › peer-review
-
Brca1 Mouse Models: Functional Insights and Therapeutic Opportunities
Yueh, W. T., Glass, D. J. & Johnson, N., Jan 1 2024, In: Journal of Molecular Biology. 436, 1, p. 168372 168372.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors
Fried, W., Tyagi, M., Minakhin, L., Chandramouly, G., Tredinnick, T., Ramanjulu, M., Auerbacher, W., Calbert, M., Rusanov, T., Hoang, T., Borisonnik, N., Betsch, R., Krais, J. J., Wang, Y., Vekariya, U. M., Gordon, J., Morton, G., Kent, T., Skorski, T. & Johnson, N. & 3 others, , Mar 5 2024, In: Nature Communications. 15, 1, p. 2862 2862.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs
Wasserman, J. S., Faezov, B., Patel, K. R., Kurimchak, A. M., Palacio, S. M., Glass, D. J., Fowle, H., McEwan, B. C., Xu, Q., Zhao, Z., Cressey, L., Johnson, N., Duncan, J. S., Kettenbach, A. N., Dunbrack, R. L. & Graña, X., Jul 10 2024, In: Nature Communications. 15, 1, p. 5776 5776.Research output: Contribution to journal › Article › peer-review
Open Access -
Structural basis for a Polθ helicase small-molecule inhibitor revealed by cryo-EM
Ito, F., Li, Z., Minakhin, L., Chandramouly, G., Tyagi, M., Betsch, R., Krais, J. J., Taberi, B., Vekariya, U., Calbert, M., Skorski, T., Johnson, N., Chen, X. S. & Pomerantz, R. T., Jul 14 2024, In: Nature Communications. 15, 1, p. 7003 7003.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Press/Media
-
Researchers at Fox Chase Cancer Center Target Cancer (Surviving Without Brca2: Mlh1 Gets R-looped In To Curtail Genomic Instability)
05/20/24
1 item of Media coverage
Press/Media
-
U.S. Patents Awarded to Inventors in New Jersey (Feb. 28)
02/28/24
1 item of Media coverage
Press/Media
-
Reports on Drug Research from Fox Chase Cancer Center Provide New Insights (Brca1 Mouse Models: Functional Insights and Therapeutic Opportunities)
02/26/24
1 item of Media coverage
Press/Media
-
Studies from Fox Chase Cancer Center Update Current Data on Science (Genetic separation of Brca1 functions reveal mutation-dependent Polth vulnerabilities)
12/7/23
1 item of Media coverage
Press/Media
-
Fox Chase Cancer Center: Study Identifies Key Mutations That Make New DNA Repair Enzyme Inhibitors More Effective
11/28/23
1 item of Media coverage
Press/Media